Dr. Alvarado is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-7070Fax+1 415-353-7050
Education & Training
- University of South Florida MorsaniFellowship, Complex General Surgical Oncology, 2004 - 2006
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Surgery, 1998 - 2004
- Geisel School of Medicine at DartmouthClass of 1998
Certifications & Licensure
- CA State Medical License 2006 - 2026
- FL State Medical License 2020 - 2022
- NH State Medical License 2001 - 2009
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery Start of enrollment: 2012 May 18
Publications & Presentations
PubMed
- Bilateral Mastectomy vs Lumpectomy and Breast Cancer Mortality Risk.Thomas J O'Keefe, Michael D Alvarado, Laura J Esserman
JAMA Oncology. 2024-12-12 - Balancing risks of surgical complications and positive margins for patients with invasive lobular carcinoma of the breast and elevated BMI: An institutional cohort study.Israel Falade, Kayla Switalla, Astrid Quirarte, Molly Baxter, Daniel Soroudi
American Journal of Surgery. 2024-11-06 - 5 citationsPredictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.Harriet T Rothschild, Elle N Clelland, Firdows Mujir, Helena Record, Jasmine Wong
Annals of Surgical Oncology. 2023-10-01
Journal Articles
- Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 PatientsMerisa Piper, Jasmine Wong, Hani Sbitany, Cheryl Ewing, Michael Alvarado, Laura Esserman, Robert Foster, Annals of Surgical Oncology
- A Natural Killer–Dendritic Cell Axis Defines Checkpoint Therapy–Responsive Tumor MicroenvironmentsPatrick K Ha, William R Ryan, Nina Bhardwaj, Vincent Chan, Michael D Alvarado, Adil I Daud, Joy Hsu, Nature
Press Mentions
- Endomag’s Sentimag and Sienna Demonstrated Non-Inferior to Standard of Care for Sentinel Node DetectionDecember 8th, 2016
- Millions Fall Prey to This Deadly Breast Cancer MythAugust 26th, 2016
- Immune-Cell Population Predicts Immunotherapy Response in MelanomaAugust 15th, 2016
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: